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Glycoprotein H (gH, UL75) of human cytomegalovirus (HCMV) is an essential envelope glycoprotein that functions in viral
entry and the activation of gene expression. To understand the regulation of this important viral gene, the promoter of the
UL75 late gene was characterized in HCMV-infected cells at the late stages of viral infection. Primer extension analysis
revealed a single major start site located 26 bp downstream of a putative TATA element. Deletion analysis showed the
presence of a dominant activation domain from 14 to 35 that masked regulatory sequences upstream of the TATA
element. Mutational analysis demonstrated that a PEA3-like element in this downstream domain was important for promoter
activation. In addition, gel shift analysis revealed direct protein binding to the PEA3-like element. Together, these studies
reveal that the gH promoter is regulated in a complex manner with sequences both upstream and downstream of the capINTRODUCTION
Human cytomegalovirus (HCMV) is a ubiquitous her-
pesvirus that infects 40–60% of the population in the
United States (reviewed in Mocarski and Courcelle,
2001). Disease caused by HCMV primarily occurs in the
immunocompromised and is an increasing problem with
the advent of AIDS and the growing numbers of organ
and bone marrow transplant recipients. Congenital
HCMV infections can also result in severe sequelae in
the infected fetus (reviewed in Pass, 2001). Infection by
HCMV is initiated by virus binding to a cellular recep-
tor(s) via envelope glycoproteins, followed by fusion of
the viral and cellular envelopes (reviewed in Mocarski
and Courcelle, 2001). Glycoprotein H (gH, UL75) is an
essential viral envelope glycoprotein (Hobom et al., 2000)
that is thought to play a key role in virus–cell fusion
(Baldwin et al., 2000; Milne et al., 1998). In addition, gH is
involved in triggering signal transduction cascades that
may assist in the initiation of viral gene expression (Yu-
rochko et al., 1997). The subsequent expression of viral
mRNAs occurs in a coordinated cascade consisting of
immediate early (IE), early, and late genes (reviewed in
Mocarski and Courcelle, 2001). The IE proteins are ex-
pressed first in permissively infected cells and are nec-
essary to trigger subsequent viral early gene expression.
The early proteins include those necessary for viral DNA
replication. Late genes are subsequently expressed after
1 To whom correspondence and reprint requests should be ad-
dressed at Department of Microbiology and Molecular Cell Biology,309viral DNA replication and typically encode viral structural
proteins, including gH.
Numerous studies have addressed the regulation of
viral early gene expression (reviewed in Fortunato and
Spector, 1999; Mocarski and Courcelle, 2001). However,
only two HCMV late promoters, UL94 and UL99, have
been studied in detail (Depto and Stenberg, 1992; Kerry
et al., 1997; Kohler et al., 1994; Wing et al., 1998). These
analyses demonstrated that little sequence upstream of
the TATA element was required to activate HCMV late
promoters. For example, UL99 sequences from 40 to
106 were sufficient to activate this promoter with wild-
type kinetics in the context of the viral genome (Kohler et
al., 1994). This finding is consistent with the analysis of
late gene regulation in herpes simplex virus (reviewed in
Roizman and Knipe, 2001), suggesting that such simple
promoter regions may be a common feature of herpes-
virus late gene regulation. For example, sequences from
50 to 33 of the UL38 late gene of herpes simplex
virus were found to be sufficient for promoter activation
(Guzowski and Wagner, 1993). However, additional ele-
ments have also been determined to influence HCMV
late gene expression. Analyses of the HCMV UL99 gene
revealed that expression is regulated posttranscription-
ally, via secondary structure in the 5 untranslated region
of the UL99 mRNA (Kerry et al., 1997), demonstrating that
more than one level of regulation may be involved in
controlling the appearance of late gene products. Anal-
ysis of the HCMV UL94 promoter in transient transfection
assays demonstrated the presence of a dominant down-
stream activation domain located from 1 to 48 (Wingsite influencing promoter activation. © 2002 Elsevier Science (U
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found to repress UL94 promoter function. This study
therefore suggests that sequences upstream of the TATA
element and downstream of the cap site can coopera-
tively regulate the expression of the UL94 late promoter
(Wing et al., 1998).
HCMV gH is part of a three-protein complex known as
gCIII, including gL (UL115) and gO (UL74) (Huber and
Compton, 1997, 1999). The gH glycoprotein is conserved
throughout known herpesviruses (Cranage et al., 1988)
and recent studies using transposon insertion mutagen-
esis strongly suggest that gH is essential for HCMV
replication (Hobom et al., 2000). Antibodies to gH have
been found to block the ability of the viral membrane to
fuse with the membrane of the host cell, implicating gH
in virus-cell fusion (Keay and Baldwin, 1991). In addition,
gH is a major target for neutralizing antibodies generated
during the natural course of infection (Urban et al., 1996).
Direct stimulation of the gH receptor by anti-idiotypic
antibodies also results in the up-regulation of the tran-
scription factors Sp1 and NF-B in fibroblasts, suggest-
ing that gH may be involved in the initiation of viral gene
expression (Yurochko et al., 1997). Together, these find-
ings indicate that gH plays a crucial role in the viral
replicative cycle and is an important target for the host
immune response.
In the present study, we characterized the promoter of
the HCMV gH late gene, UL75, in HCMV-infected cells at
the late stages of viral infection. Primer extension anal-
ysis was used to map the 5 end of the mRNA. Deletion
analysis revealed the presence of a dominant activation
domain downstream of the mRNA start site that masks
both activation and repression domains within upstream
promoter sequences. The downstream activation domain
contains a consensus binding site for the cellular tran-
scription factor PEA3. Mutation of this site resulted in the
abrogation of promoter activity and gel shift analysis
revealed a protein present in cells at late times of infec-
tion that specifically bound to the PEA3-like element.
Intriguingly, deletion of this downstream sequence re-
sulted in a construct with wild-type promoter activity,
suggesting that this region may also contain a binding
site for a repressor. Together, our results demonstrate a
complex mechanism of regulation of this HCMV late
gene, with the PEA3-like element playing a critical role in
UL75 promoter activation.
RESULTS
Mapping the UL75 transcriptional initiation site
Previous analysis of HCMV late promoters demon-
strated that sequences located downstream of the cap
site had significant effects on promoter activity (Depto
and Stenberg, 1992; Kerry et al., 1997; Kohler et al., 1994;
Wing et al., 1998). To assess if this was also the case for
the UL75 promoter, we first localized the site of transcrip-
tional initiation by primer extension analysis (Fig. 1A). An
oligonucleotide primer was designed complementary to
sequences 108 bp downstream of the putative TATA
element of the UL75 promoter. Primer extension of RNA
isolated from human fibroblast cells (HFF) at the late
stages of infection showed a prominent intense band of
82 bp in length (Fig. 1) that was not present in an
identically treated sample from uninfected HFF cells.
This experiment therefore identifies the major transcrip-
tional initiation site as 26 bp downstream of the TATA
element (Fig. 1B). Some additional, less intense bands
were also detected that likely represent premature ter-
mination of the primer extension due to secondary struc-
ture within the GC rich 5 end of the UL75 mRNA, or
products of minor transcription start sites.
Deletion analysis of the UL75 promoter
In order to assess the sequences required for pro-
moter activation, we cloned UL75 promoter sequences
from 453 to 35 into the reporter vector pSV0CAT to
generate pUL75CAT. Sequence analysis using the DNA-
sis program demonstrated that this region contains a
number of elements that may be involved in transcrip-
tional activation (Fig. 1B). In addition, the UL75 promoter
was found to contain a region from 1 to 6 with some
sequence similarity to a DAS element (Guzowski et al.,
1994; Guzowski and Wagner, 1993; Petroski et al., 2001).
This element was originally identified downstream of the
cap site of the herpes simplex virus UL38 late promoter,
and has been shown to be required for activated tran-
scription of this promoter (Guzowski and Wagner, 1993).
To determine sequences necessary for UL75 promoter
activation, a series of deletion constructs were gener-
ated removing sequences both upstream and down-
stream of the transcriptional initiation site (Fig. 2A). The
deletion constructs were then transfected into HFF cells
and evaluated for their response to viral infection. These
experiments show that deletion of sequences from453
to 38 in the presence of promoter elements from 14
to 35 had no significant effect on UL75 promoter activ-
ity (Fig. 2B), suggesting that sequences upstream of the
TATA element are not essential for UL75 promoter acti-
vation.
Analysis of the HCMV UL94 late promoter demon-
strated that downstream promoter elements worked in
combination with upstream elements to regulate tran-
scription (Wing et al., 1998). To assess if a similar mech-
anism was involved in the regulation of UL75 promoter
activity, sequences from 14 to 35 were deleted and
assessed for the effect on promoter activation. In the
context of UL75 promoter sequences from 453, dele-
tion of the region from 14 to 35 resulted in no signif-
icant change in promoter activity (Figs. 2B and 3). In
contrast, combining the deletion from 14 to 35 with
deletion of sequences from 453 to 245 resulted in a
significant increase in activity, to approximately twice
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that of the intact UL75 promoter region. This finding
suggests that the sequences from 453 to 245 may
contain a repressor element. Alternatively, this effect may
be nonspecific, as similar increases in promoter activity
have been observed in analyses of several other HCMV
promoter regions (J. A. Kerry, unpublished observations).
Further deletion of sequences from 245 to 117 in
the context of the 14 to 35 deletion resulted in a
significant reduction in promoter activity, suggesting that
sequence elements between 245 and 117 are in-
volved in the activation of the UL75 promoter function
(Fig. 2B). This effect is observed only in the absence of
the 14 to 35 sequence, implying that this region
functions as a dominant downstream domain, similar to
that observed in the UL94 promoter. Additional deletion
of the 117 to 81 sequence resulted in a significant
2.5-fold increase in activity, suggesting the presence of a
repressor element between 117 and 81. Subsequent
deletion of sequences from 81 to 38 in the absence
of the region from 14 to 35 results in a decrease in
promoter activity to a level similar to that of the wild-type
promoter construct, indicating the presence of another
activation domain between 81 and 38. Together,
these data show that in the absence of sequences from
14 to 35, elements upstream of the TATA box can
function to both positively and negatively regulate UL75
promoter activity. In addition, they suggest that the se-
quences from 14 to 35 may act as a dominant do-
FIG. 1. (A) Primer extension analysis of the UL75 promoter. Total cellular RNA from infected (I) and mock-infected (M) HFFs was subjected to primer
extension analysis to map the UL75 transcriptional start site. The size of the extension products was assessed by comparison with a radiolabeled
DNA ladder (L). The sizes of the ladder DNA are indicated on the right. (B) Sequence of the UL75 promoter region. Consensus transcription factor
binding elements are indicated in bold. In cases where sequences overlap, one of the sequences is underlined and the other italicized. The location
of the label denotes the orientation of the consensus element. The UL75 transcription start site (1), TATA box, and the UL76 start codon are also
indicated.
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main. Further, sequences from 38 to 14 are sufficient
to activate the UL75 promoter in the context of transient
assays.
Mutational analysis of the UL75 promoter
Deletion analysis suggested that sequences from14
to 35 might play an important role in the regulation of
UL75 promoter function. This region contains two con-
sensus enhancer elements, a W-element (Cogswell et
al., 1990, 1991) and a putative PEA3 binding site (Wasylyk
et al., 1990; Xin et al., 1992). To assess the role of these
sequences in UL75 promoter activation, nucleotide sub-
stitutions were generated in the context of the full-length
promoter (Fig. 3). The UL75 promoter constructs contain-
ing the mutated W-element or PEA3-like element were
transfected into fibroblasts and evaluated for their re-
sponse to viral infection (Fig. 3). These analyses demon-
strated that mutation of the W-element had no effect on
UL75 promoter activity, indicating that this element is not
required for promoter function. In contrast, mutation of
the PEA3-like element resulted in a six- to sevenfold drop
in UL75 promoter activity. Similar effects were observed
when the PEA3 site was mutated in the context of the
minimal promoter construct from 38 to 35 (data not
shown). These findings suggest that the PEA3-like ele-
ment may play a critical role in the regulation of UL75
promoter function. This was somewhat surprising, as
deletion of this region had no significant effect on pro-
moter activity in the context of the minimal promoter
construct. To determine if other sequence elements
within the minimal promoter region from 38 to 14
could also be involved in UL75 regulation, a series of
scanning mutants between25 and9 were generated,
including a mutation of the putative DAS element. Anal-
ysis of these mutants demonstrated that no individual
sequence element within the minimal promoter had a
significant impact on promoter activation (data not
shown). Thus, the PEA3-like element appears to be the
primary functional element within this region.
Protein binding analysis of the UL75 promoter
Our analysis of the UL75 promoter revealed that a
PEA3-like element downstream of the transcriptional ini-
tiation site was important for transcriptional activation.
We therefore assessed the ability of proteins present
within both infected and uninfected cells to bind to this
sequence element (Fig. 4). These studies demonstrate
the presence of a protein within nuclear extracts isolated
from infected cells at late times after viral infection that
bound specifically to the PEA3-like element (Band P).
FIG. 3. (Top) Sequence from 14 to 35 of the UL75 promoter
elements. The consensus binding sites for the W-element and PEA3
proteins are indicated. Mutations of these elements are shown under-
neath the sequence with the mutated nucleotides underlined. (Bottom)
Activation of UL75 promoter mutations by viral infection. Constructs
containing mutations of the UL75 promoter in the context of the full-
length promoter were assessed by transfection–superinfection analy-
sis as described under Materials and Methods. Activity is expressed
relative to the wild-type promoter at 100%. The average ( standard
deviation) from at least two experiments performed in duplicate is
shown. UL75, pUL75CAT; UL75, pUL75CAT; UL75WX, pUL75CATWX;
UL75PX, pUL75CATPX. *P  0.01 (Student’s t test).
FIG. 2. (A) Schematic diagram of the UL75 promoter. Deletions
generated within the promoter region are indicated (St, StuI; B, BstBI; S,
SmaI). (B, C) Activation of UL75 promoter deletions by viral infection. (B)
Constructs containing deletions of the UL75 promoter in the presence
or absence () of sequences from 15 to 35 were assessed by
transfection–superinfection analysis as described under Materials and
Methods. Activity is expressed relative to the wild-type promoter at
100%. The average ( standard deviation) from at least two experiments
performed in duplicate is shown. gH, pUL75CAT; gH, pUL75CAT;
245, pUL75CAT245; 245, pUL75CAT245; 117, pUL75CAT117; 117,
pUL75CAT117; 81, pUL75CAT81; 81, pUL75CAT81; 38, pULCAT38;
38, pUL75CAT38. *Significant differences (P  0.05), based on
Student’s t tests performed on the analysis of the UL75 mutants in the
absence of sequences from 15 to 35.
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The two additional bands detected in the gel shift anal-
ysis represent nonspecific binding products. Competi-
tion analysis revealed that Band P could be competed
with 100-fold excess of the wild-type probe, but not with
DNA containing a mutation in the PEA3-like element. In
addition, we were unable to detect this band in nuclear
extracts isolated from uninfected cells. Thus, it is likely
that this protein is involved in the activation of the UL75
promoter. PEA-3 is a member of the ets family of tran-
scription factors, and actually consists of a family of
related proteins (de Launoit et al., 1997). To further char-
acterize the specific factor binding to the PEA3-like ele-
ment, we performed competition analysis using oligonu-
cleotides containing consensus ets and PEA3 binding
elements, as well as oligonucleotides containing muta-
tions of the consensus binding sites. These studies dem-
onstrated that oligonucleotides containing either the ets
or PEA3 consensus binding sites were both capable of
competing efficiently for binding to the UL75 PEA3-like
element (data not shown). In contrast, oligonucleotides
containing the mutated ets and PEA3 elements were
unable to compete for binding to the UL75 PEA3-like
element, implying that the protein binding to this element
is closely related to the ets/PEA3 family of transcription
factors, or is a unique protein with a similar binding site.
Interestingly, we also detected a different protein–DNA
complex within infected cell nuclear extracts when we
used the probe containing the mutated PEA3-like ele-
ment (Band PX). This protein–DNA complex was effi-
ciently competed with the PX probe, but only poorly
competed with 100-fold excess of the wild-type DNA
fragment. This finding suggests that proteins present
within the infected cell at late times may be able to bind
to the DNA in the absence of the PEA3-like element that
potentially play a role in transcriptional regulation via this
region.
DISCUSSION
Gene expression in HCMV-infected cells is a complex
process that is controlled by both viral and cellular pro-
teins (reviewed in Fortunato and Spector, 1999; Mocarski
and Courcelle, 2001). The goal of this study was to
characterize sequences required for activation of the gH
(UL75) late promoter. These analyses demonstrated that
sequences downstream of and including the TATA ele-
ment are primarily responsible for activation of the UL75
promoter in HCMV-infected cells at the late stages of
infection. Specifically, sequences from 38 to 35 were
found to be sufficient for activation. This finding is similar
to the analysis of the UL94 and UL99 HCMV late promot-
ers, as well as herpes simplex virus late promoters. In
these investigations, it was determined that sequences
upstream of the TATA element were not required for late
promoter activation both in transient transfection assays
and in the context of the viral genome (Depto and Sten-
berg, 1992; Kohler et al., 1994; Roizman and Knipe, 2001;
Wing et al., 1998). However, in the analyses of HCMV late
gene expression, no specific element required for acti-
vation of the HCMV late promoters had been identified.
In the present study, we have characterized a specific
element that significantly impacts on the activation of the
UL75 late promoter. Our studies identified a PEA3-like
element located at 23 to 28 within the minimal UL75
promoter region that significantly impacted on UL75 pro-
moter activity. In support of a role for this element in
UL75 promoter activation, we identified a protein present
within late infected cells that specifically bound to the
wild-type PEA3-like element. Competition analysis dem-
onstrated that the protein binding to this element is likely
closely related to the ets/PEA3-family of transcription
factors.
Analysis of the HCMV UL99 late promoter had re-
FIG. 4. Gel-shift analysis of proteins binding to the UL75 promoter region. Oligonucleotide probes containing either the wild-type PEA3-like element
(PEA3) or the PX mutation (PXp) were assessed by gel shift analysis using nuclear extracts isolated from mock-infected HFFs (M) or cells infected
for 72 h (I). Competition analysis was carried out with 100-fold excess of either the wild-type sequence (Pc) or the mutated probe DNA (PXc). Two
specific bands, P and PX, associated with the PEA3 probe or mutated probe, respectively, are indicated by the arrows.
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vealed that expression of this gene is regulated at the
level of translation via a stem–loop structure within the
5-untranslated region (Kerry et al., 1997). However, the
UL75 downstream sequences, while relatively GC-rich,
did not contain sequences that would permit the forma-
tion of a stable stem–loop structure. Therefore, it is most
likely that UL75 regulation via the PEA3-like site occurs
at the level of transcription. Our previous analyses of the
UL99 promoter determined that regions critical in tran-
scriptional activation identified using transient assays
are also involved in the regulation of gene expression in
the context of the viral genome (Depto and Stenberg,
1992; Kerry et al., 1997; Kohler et al., 1994), demonstrating
that transient transfection analysis is a valid method to
identify elements involved in the regulation of HCMV late
gene expression. To confirm the role of the PEA3-like
element in UL75 promoter regulation, we are currently
inserting the UL75 promoter derivatives into the viral
genome to assess the effects of the promoter mutations
in the context of a natural infection.
Our analysis of the minimal UL75 promoter region
revealed that deletion from 14 to 35 resulted in a
promoter construct with activity similar to that of the
wild-type promoter region. Within these sequences,
scanning mutational analysis did not reveal any single
region that significantly impacted on UL75 promoter ac-
tivity, implying that the TATA element was sufficient for
UL75 promoter activation by viral proteins. This was
somewhat surprising, as mutational analysis clearly
demonstrated that the PEA3-like element is required for
UL75 promoter activation. In the context of the mutated
PEA3-like element, we hypothesize that the mutated se-
quences may bind a protein that blocks activation of the
UL75 promoter. This hypothesis is supported by the
direct binding analysis using the PX probe (Fig. 4) that
revealed a specific protein binding to the PX region in
infected cell nuclear extracts. One possibility is that the
specific mutation introduced in this region resulted in the
formation of a binding site for a different transcription
factor. Screening of the mutated sequence using the
TRANSFAC database revealed that this mutation re-
sulted in a partial binding site for thyroid transcription
factor 1 (Wingender et al., 2000). This factor is expressed
only in thyroid, lungs, and the developing brain (Guazzi et
al., 1990) and thus is unlikely to play a role in regulating
the UL75 promoter in fibroblasts. Alternatively, the factor
binding to the PX region may have a specific function in
UL75 promoter regulation. For example, it is possible that
this region of the promoter may bind two proteins, the
PEA3-like factor and a putative repressor protein. In the
presence of the wild-type sequence element, proteins
binding to the PEA3-like element would prevent binding
of this novel protein to the UL75 promoter. Similarly,
deletion of this region would result in an inability of the
repressor to bind, resulting in a loss of repression of the
UL75 promoter. Identification of the proteins that bind to
both the wild-type and the mutated sequences will en-
able us to characterize the precise role of these proteins
in the regulation of the UL75 promoter via the PEA3-like
element.
Our deletion analysis suggested that the region from
14 to 35 functioned as a dominant downstream con-
trol element that masks the effect of potential activation
and repression domain elements upstream of the TATA
box. A similar phenomenon was observed with the UL94
late promoter (Depto and Stenberg, 1992; Kohler et al.,
1994; Wing et al., 1998). One likely reason for multiple
control elements within the promoters of HCMV genes is
related to the variety of cell types that HCMV infects in
vivo. For example, the PEA3 protein is expressed in
fibroblasts and epithelial cells, but not in cells of the
hematopoietic system (Xin et al., 1992). As HCMV infects
both hematopoietic progenitor cells and macrophages
(Mocarski and Courcelle, 2001), alternate mechanisms
for activation of the UL75 promoter may be required for
efficient expression of this essential viral gene. In future
studies, we will directly assess UL75 promoter activation
in other permissive cell types in order to test this hypoth-
esis. In summary, these studies demonstrate that HCMV
late promoter activation is a complex process in which
both activators and repressors combine to carefully con-
trol the expression of these essential viral genes.
MATERIALS AND METHODS
Plasmids
The UL75 promoter region from nucleotide 110208 to
110694 (Chee et al., 1990) was cloned into a modified
pUC12 vector (pUCHH) with a HindIII site at each end of
the multiple cloning site (MCS). The 488-bp UL75 pro-
moter sequences were cloned into the CAT reporter
vector pSV0CAT (Depto and Stenberg, 1989) to generate
pUL75 CAT. The UL75 promoter deletion mutants
pUL75CAT245 and pUL75CAT117 were generated by di-
gestion with either StuI (245) or BstBI (117) and a PstI
site located in the pUCHH MCS, followed by religation of
the vector DNA. The resultant truncated promoter frag-
ments were subcloned as HindIII fragments into
pSV0CAT. Additional deletions were generated using a
PCR mutagenesis strategy (Chau et al., 1999) designed
to introduce HindIII sites at 81 (pUL75CAT81: primers
81f 5-GCAAAGCTTACTCGCGTGTCCCCTCTTCTC and 81r
5-GAGAAGAGGGGACACGCGAGTAAGCTTTGC; mutated
sequences indicated in bold) and38 (pUL75CAT38: prim-
ers 38f 5-CCCTTCGCAGCGGCCAAGCTTATCGTATTAAAT-
AGACG and 38r 5-CGTCTATTTAATACGATAAGCTTGGC-
CGCTGCGAAGGG) in the UL75 promoter. The resultant
truncated HindIII fragments were consequently sub-
cloned into the CAT reporter vector. Deletion of se-
quences from 15 to 35 (pUL75CAT) was accom-
plished by digestion with a SmaI site that cuts at 14 in
the UL75 promoter and at the 3 end of the promoter.
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Promoter variants containing mutations of the W-element
(pUL75CATWX) and PEA3 site (pUL75CATPX) were gen-
erated by cloning oligonucleotide fragments containing
sequences from 15 to 35 with the mutated element
into the SmaI site. The primers used are shown with the
mutated region indicated in bold: WXf 5, CCGGTCTA-
GACTTCCTGGGATCC; WXr 5, CCGGGGATCCCAGGA-
AGTCTAGA; PXSf 5, CCGGTGCTCTCTAGAGGGATCC;
PXSr 5, CCGGGGATCCCTCTAGAGAGCAC.
Cells and transfection assays
Primary HFFs were transfected with 10 g of DNA by
the DEAE-dextran method as previously described
(Depto and Stenberg, 1989). Twenty-four hours after
transfection the cells were infected with HCMV strain
Towne. Cells were harvested 72 h after infection and
assessed for CAT enzyme activity (Depto and Stenberg,
1989).
Primer extension analysis
Total cellular RNA was isolated from mock-infected
and HFF cells infected for 72 h to allow for late gene
expression using the RNeasy system as described in the
manufacturer’s protocol (Qiagen, Chatsworth, CA). The
RNA samples were subjected to primer extension anal-
ysis as previously described (Triezenberg, 1992) using
the oligo UL75primerext 5-GTGATCCAGGTGGTGGTTG-
GCGTTAC.
Gel shift assays
Nuclear extracts from HFF cells infected for 72 h or
mock-infected were isolated as previously described
(Kerry et al., 1994). Gel shift analysis was also performed
as previously described except that 0.2 to 1 g of the
nonspecific competitor poly(dI-dC) was used (Chau et al.,
1999). Probes containing wild-type sequences were gen-
erated by annealing the oligonucleotides Pf 5-GGT-
GCTCCTTCCTGGGATCC and Pr 5-GGATCCCAGGAAG-
GAGCACC. The PX probe was generated by annealing
PXf 5-GGTGCTCTCTAGAGGGATCC and PXr 5-GGA-
TCCCTCTAGAGAGCACC. Oligonucleotides containing
consensus ets and PEA3 sites and their mutated deriv-
atives used in competition experiments were all obtained
from Santa Cruz Biotechnology (Santa Cruz, CA).
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